| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.0M | +23.9% |
| Cost of Revenue | $3.9M | +121.4% |
| Gross Profit | $13.1M | +9.6% |
| R&D Expense | $6.8M | +19.1% |
| SG&A Expense | $8.3M | +10.6% |
| Operating Income | -$2.0M | -57.5% |
| Pre-tax Income | -$2.1M | -58.8% |
| Income Tax | $615K | +202.4% |
| Net Income | -$2.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | -100.0% |
| Inventory | $27K | -30.5% |
| Current Assets | $4.9M | +25.6% |
| Total Assets | $7.0M | +8.1% |
| Current Liabilities | $6.3M | +86.6% |
| Total Liabilities | $7.3M | +57.9% |
| Stockholders' Equity | -$292K | -115.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$998K | -4755.9% |
| Investing Cash Flow | -$727K | -1451.7% |
| Financing Cash Flow | $1.3M | +246.9% |
| -283.7% |
| EPS (Basic) | -$0.18 | -260.0% |
| EPS (Diluted) | -$0.18 | -260.0% |